Results 121 to 130 of about 3,875 (181)

One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol. [PDF]

open access: yesBlood Cancer J
Yousuf M   +17 more
europepmc   +1 more source

CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML

open access: yesBlood Advances, 2018
Claire M. Lucas   +6 more
doaj   +1 more source

Similar androgen receptor expression in male and female AML. [PDF]

open access: yesBlood Adv
Prabhu KS   +4 more
europepmc   +1 more source

Survival of myelodysplastic syndrome patients after azacitidine therapy. [PDF]

open access: yesBMC Cancer
Thammagul K   +5 more
europepmc   +1 more source

Changes in allele frequencies of CSF3R and SETBP1 mutations and evidence of clonal evolution in a chronic neutrophilic leukemia patient treated with ruxolitinib

open access: yesHaematologica, 2017
Zohra Nooruddin   +9 more
doaj   +1 more source

Assessment of the IPSS-M in chronic myelomonocytic leukemia. [PDF]

open access: yesBlood Adv
Palomo L   +35 more
europepmc   +1 more source

TP53 Mutations Unfavorably Impact the Outcomes of Myelofibrosis Patients with or Without Hematopoietic Stem Cell Transplantation: A Single-Center Study and Meta-Analysis. [PDF]

open access: yesInt J Mol Sci
Frioni F   +15 more
europepmc   +1 more source

Schinzel-Giedion syndrome: communication, feeding and motor skills in 16 individuals. [PDF]

open access: yesNeurogenetics
Morison LD   +4 more
europepmc   +1 more source

CRISPR-engineered human GATA2 deficiency model uncovers mitotic dysfunction and premature aging in HSPCs, impairing hematopoietic fitness. [PDF]

open access: yesLeukemia
Romero-Moya D   +19 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy